Related Experiment Video
Updated: Jun 1, 2026
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
[Colorectal cancer and diabetes]
1III. Interní klinika 1. lékarské fakulty UK a VFN Praha. svacinas@lf1.cuni.cz
Vnitrni Lekarstvi
|May 27, 2011
Summary
Metformin may reduce colorectal cancer risk in type 2 diabetes patients. Lifestyle changes and regular colonoscopies are key for prevention in this high-risk group.
Area of Science:
- Oncology
- Endocrinology
- Gastroenterology
Context:
- Colorectal carcinoma (CRC) incidence is elevated in patients with type 2 diabetes and obesity.
- Prediabetic states are also associated with a slightly increased CRC risk.
- Type 2 diabetes patients are a recognized risk group for CRC.
Purpose:
- To review the relationship between type 2 diabetes, obesity, prediabetes, and colorectal cancer.
- To highlight recent findings regarding metformin's role in CRC risk reduction.
- To discuss preventive strategies for colorectal carcinoma in at-risk populations.
Summary:
- Metformin use is associated with a reduced risk of colorectal carcinoma.
- Prescribing metformin is trending for patients with disturbed glucose tolerance or hyperglycemia.
- Preventive measures include regular physical activity, a diet rich in fruits and vegetables, reduced animal fat intake, and colonoscopy.
- Alterations in intestinal flora may play a role in CRC pathogenesis.
Impact:
- Metformin may offer a chemopreventive benefit against colorectal cancer in diabetic patients.
- Targeted prevention strategies should focus on individuals with type 2 diabetes.
- Lifestyle modifications and regular screening are crucial for reducing CRC incidence and mortality in high-risk groups.
Related Concept Videos
01:19Psychoneuroimmunology: Diabetes and Cancer
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...